XML 233 R205.htm IDEA: XBRL DOCUMENT v3.25.1
Commitments and Contingencies (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Schedule of Other Information related to Stamford Lease, Lease Amendment and New Lease

The components of lease costs, which are included within general and administrative expenses in the Company’s condensed statements of operations and comprehensive loss were as follows (in thousands):

    

For the Three Months Ended March 31,

    

2025

    

2024

Lease costs:

 

  

 

  

Operating lease cost

$

24

$

22

Variable lease cost

 

22

 

21

Total lease costs

$

46

43

The components of lease costs, which are included within general and administrative expenses in the Company’s statements of operations were as follows (in thousands):

    

For the Year Ended

December 31,

    

2024

    

2023

Lease costs:

 

  

 

  

Operating lease cost

$

96

$

90

Variable lease cost

 

80

 

83

Total lease costs

$

176

 

173

Schedule of Future Minimum Lease Payments under Non-cancellable Operating Leases, Reconciliation of Undiscounted Cash Flows to the Operating Lease Liabilities

As of March 31, 2025, the maturities of the Company’s operating lease liabilities were as follows (in thousands):

Year Ended December 31,

    

Amount

2025 (remaining nine months)

$

95

2026

 

129

2027

 

88

Total lease payments

 

312

Less: imputed interest

 

(32)

Present value of lease liabilities

 

280

Less: operating lease liabilities, current portion

$

106

Operating lease liabilities, net of current portion

$

174

As of December 31, 2024, the maturities of the Company’s operating lease liabilities were as follows (in thousands):

Year Ended December 31,

    

Amount

2025

$

126

2026

 

129

2027

 

88

Total lease payments

 

343

Less: imputed interest

 

(39)

Present value of lease liabilities

 

304

Less: operating lease liabilities, current portion

$

103

Operating lease liabilities, net of current portion

$

201

Cara Therapeutics, Inc.    
Schedule of activity related to the Company's restructuring action  

Total restructuring expense recorded during the year ended December 31, 2024

    

$

5,689

Payments made during the year ended December 31, 2024

(5,515)

Reversal of restructuring provision during the year ended December 31, 2024

 

(124)

Remaining amount to be paid as of December 31, 2024

$

50

Schedule of Other Information related to Stamford Lease, Lease Amendment and New Lease

Three Months Ended
March 31,

    

2025

    

2024

Cash paid for amounts included in the measurement of lease liabilities:

 

  

 

  

Operating cash outflows relating to operating leases

$

$

ROU assets obtained in exchange for new operating lease liabilities

$

$

Remaining lease term - operating leases (years)

 

 

10.6

Discount rate - operating leases

 

%  

12.8

%  

Year Ended December 31,

 

    

2024

    

2023

 

Cash paid for amounts included in the measurement of lease liabilities:

 

  

 

  

Operating cash outflows relating to operating leases

$

4,363

$

1,992

ROU assets obtained in exchange for new operating lease liabilities

$

$

6,779

Remaining lease term - operating leases (years)

 

 

10.8

Discount rate - operating leases

 

%  

12.8

%